Limitations include the cross-sectional design, there being no information on nadir CD4+ T cell counts, and the fact that a comparison between different types of COVID-19 vaccines was not performed due to the small sample size of participants who did not receive the mRNA-1273 or BNT162b2 mRNA COVID-19 vaccines. The gene discussed is CD4; the disease is COVID-19.